Axoltis Pharma is a biopharmaceutical company dedicated to develop first-in-class disease-modifying drugs to treat patients with degenerative or traumatic neurological disorders with high unmet medical needs.

Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders.


Our products are a first-in-class multi-target peptides with high potential in many CNS disorders, as demonstrated via distinctive and multifunctional mechanism of action on neural cells, encompassing:

  • Neuroprotection with strong anti-oxidative properties & anti-apoptotic activities
  • Regenerative & remodeling properties including neurite outgrowth to restore lost function
  • Cellular plasticity mechanisms